Clinical trials: Hemodialysis-Induced Symptom
Anemia, End Stage Renal Disease
16-Week Repeat Oral Dose Study of AKB-6548 for Anemia in Participants With End Stage Renal Disease (ESRD) Requiring Chronic Hemodialysis
The purpose of this study is to evaluate the hemoglobin response (efficacy), safety, and tolerability of orally administered AKB-6548 in participants with end stage renal disease undergoing chronic hemodialysis.
- Trial name
- NCT02260193
- Testing
- AKB-6548
- Where
- 16 sites in United States
- Volunteers
- 94 people
- Sponsor
- Akebia Therapeutics
Hemodialysis Complication, Hemodialysis-Induced Symptom
Relationship Between Hemodynamic Change and Fluid Removed During Hemodialysis
Relationship between hemodynamic change and fluid removed during hemodialysis measured by non-invasive monitor
- Trial name
- NCT03901794
- Testing
- Non-invasive hemodynamic monitor
- Where
- Taiwan
- Volunteers
- 60 people
- Sponsor
- National Taiwan University Hospital
Intradialytic Hypotension, Hemodialysis-Induced Symptoms
Timing of Intradialytic Exercise and Its Impact on Intradialytic Hypotension
The objective of this study is to compare the rate of low blood pressure events (Intradialytic Hypotension: IDH) when intradialytic exercise is performed in the first half of the hemodialysis (HD) session as compared to that when…
- Trial name
- NCT03504943
- Testing
- Early Intradialytic Exercise, Late Intradialytic Exercise
- Where
- 3 sites in Canada
- Volunteers
- 112 people
- Sponsor
- University of Manitoba
Fluid Overload, Dialysis; Complications
ULtrafiltration-Rate Induced CArdiac Strain (ULRICA) - Study
Patients performing chronic hemodialysis (HD) retain more or less water between dialyses. The water is removed by ultrafiltration and usually during the cleansing of waste products - the HD.
- Trial name
- ULRICA (NCT06153888)
- Testing
- Ultrafiltration rate
- Where
- Sweden
- Volunteers
- 40 people
- Sponsor
- Umeå University
Hemodialysis-Induced Symptom
Factors Influencing Hemoglobin Variability and Its Association With Mortality in Hemodialysis Patients
The aim of the study is to investigate the factors influencing hemoglobin variability with inflammatory and nutritional parameters and its associations with all-cause mortality among hemodialysis patients.
- Trial name
- NCT03454906
- Volunteers
- 169 people
- Sponsor
- Baskent University
Hemodialysis-Induced Symptom, Intra-dialytic Hypotension
To Evaluate the Effects of Heating Device (Electronic Moxibustion) in Patients With Intradialytic Hypotension
The aim of this study is to investigate the effects of heating device among otherwise stable patients with intradialytic hypotension
- Trial name
- NCT03856151
- Testing
- "HEALTHY BOX" Powered heating pad (electronic moxibustion)
- Where
- Taiwan
- Volunteers
- 32 people
- Sponsor
- Chang Gung Memorial Hospital
Haemodialysis-induced Symptom
Sleep Quality and Related Factors in Hemodialysis Patients
Sleep quality is an important predictor of healthy status,quality of life and life span. Sleeping problems affect 50%~80% in hemodialysis patients.
- Trial name
- NCT01327560
- Where
- Taiwan
- Volunteers
- 200 people
- Sponsor
- Taipei Medical University WanFang Hospital
End Stage Renal Disease, Chronic Pain
HOPE Consortium Trial to Reduce Pain and Opioid Use in Hemodialysis
HOPE is a randomized clinical trial that will evaluate approaches to reducing pain and opioid use among patients with chronic pain who are receiving maintenance hemodialysis for end-stage renal disease.
- Conditions
- End Stage Renal Disease, Chronic Pain, Opioid Dependence
- Trial name
- HOPE (NCT04571619)
- Testing
- Pain Coping Skills Training (PCST), Buprenorphine
- Where
- 16 sites in United States
- Volunteers
- 643 people
- Sponsor
- National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)
Sarcopenia, Anemia Associated With Chronic Kidney Disease (CKD)
Hypoxia-inducible Factor Prolyl Hydroxylase Inhibitors on Sarcopenia in Hemodialysis Patients
Sarcopenia, abbreviated as muscle loss, is a prevalent complication among patients with chronic kidney disease (CKD), particularly those with end - stage renal disease (ESRD). It significantly impacts patients' quality of life.
- Conditions
- Sarcopenia, Anemia Associated With Chronic Kidney Disease (CKD), Dialysis Patients
- Trial name
- HIF-PHI (NCT07162090)
- Testing
- Roxadustat, Recombinant human erythropoietin (EPO)
- Volunteers
- 60 people
- Sponsor
- Tianjin Medical University General Hospital
Dialysis Related Complication, Dialysis Hypotension
Expanded Hemodialysis Versus Online Hemodiafiltration
Conventional hemodialysis (HD) is essential for the treatment of end-stage renal disease (ESRD) patients, by reducing serum concentration of uremic toxins and correcting fluid overload.
- Conditions
- Dialysis Related Complication, Dialysis Hypotension, Hemodialysis-Induced Symptom
- Trial name
- NCT03274518
- Testing
- Expanded Hemodialysis, Online Hemodiafiltration
- Where
- Brazil
- Volunteers
- 16 people
- Sponsor
- University of Sao Paulo
Renal Failure Chronic Requiring Hemodialysis, Haemodialysis-induced Symptom
Mechanisms of Intradialytic Hypertension
Patients with end-stage renal disease (ESRD) are at significantly higher risk for death due to cardiovascular disease. Those with paradoxical increases in blood pressure (BP) during hemodialysis (HD), defined as intradialytic…
- Conditions
- Renal Failure Chronic Requiring Hemodialysis, Haemodialysis-induced Symptom, Hypertension
- Trial name
- MID-H (NCT01947673)
- Testing
- Mindfulness Meditation, Health Education
- Where
- United States
- Volunteers
- 49 people
- Sponsor
- Emory University
Opiate Addiction
Opiate Detoxification Using the Combined Hemoperfusion-hemodialysis
The purpose of this study is to determine whether combined hemoperfusion-hemodialysis treatment is an alternative drug-free, effective, and safe treatment for opiate detoxification.
- Trial name
- HPDMT (NCT01021566)
- Testing
- Combined hemoperfusion-hemodialysis, Methadone
- Where
- China
- Volunteers
- 60 people
- Sponsor
- First People's Hospital of Foshan
ESRD, Fatigue
The Effect of Blood Flow Rate on Dialysis Recovery Time in Patients Undergoing Maintenance Hemodialysis
A majority of patients with end-stage renal disease (ESRD) on in-center hemodialysis (HD) require several hours to recover from fatigue after an HD session.
- Conditions
- ESRD, Fatigue, Hemodialysis-Induced Symptom
- Trial name
- NCT03943212
- Testing
- Blood Flow Rate Reduction, Control
- Where
- 18 sites in United States
- Volunteers
- 102 people
- Sponsor
- Satellite Healthcare